Pharmacopeia Announces Completion of Public Stock Offering - PR Newswire (press release)
May 8, 2007| Pharmacopeia Announces Completion of Public Stock Offering PR Newswire (press release), NY - ... disease (COPD) and four partnered programs in Phase 1 clinical trials targeting rheumatoid arthritis, oncology, metabolic and inflammatory diseases. ... |
Pharmacopeia Announces Completion of Public Stock Offering - PharmaLive.com (press release)
May 8, 2007| Pharmacopeia Announces Completion of Public Stock Offering PharmaLive.com (press release), PA - ... disease (COPD) and four partnered programs in Phase 1 clinical trials targeting rheumatoid arthritis, oncology, metabolic and inflammatory diseases. ... |
Chronic inflammation leads to other risks - HeraldNet
May 8, 2007| Chronic inflammation leads to other risks HeraldNet, WA - For instance, people with autoimmune disorders such as rheumatoid arthritis or lupus have an increased risk for coronary heart disease. Why? ... |